There is no single best arthritis medication because the right choice depends on which type of arthritis you have, how severe it is, and your personal health risks. Osteoarthritis, rheumatoid arthritis, and psoriatic arthritis each respond to different drug classes, and even within one type, the ideal medication shifts based on factors like your age, heart health, and stomach sensitivity. What follows is a practical breakdown of the most effective options for each major form of the disease.
Osteoarthritis: NSAIDs Are the Standard
For osteoarthritis, the wear-and-tear form that affects most people, anti-inflammatory painkillers known as NSAIDs remain the go-to treatment. Common over-the-counter options include ibuprofen and naproxen. Prescription-strength versions and a selective type called celecoxib are also widely used. The American College of Rheumatology recommends using the lowest effective dose for the shortest time needed, since long-term use raises the risk of stomach ulcers, kidney problems, and cardiovascular events.
If your arthritis is in the knee, topical NSAIDs (gels or creams applied directly to the skin) can work nearly as well as pills for short-term pain relief. Guidelines note that oral and topical NSAIDs offer equivalent pain reduction and improved function for knee osteoarthritis. Topical forms expose your body to far less of the drug overall, which makes them a smarter first step if you’re concerned about side effects. They’re less practical for deeper joints like the hip, where the medication can’t penetrate effectively through layers of tissue.
How NSAIDs Compare on Heart Risk
Not all NSAIDs carry the same cardiovascular risk, and this matters if you’ll be using one regularly. A large meta-analysis published in The Lancet, pooling data from randomized trials, found that naproxen stood apart from other common options. Celecoxib and diclofenac each increased the risk of a major cardiovascular event (heart attack, stroke, or vascular death) by roughly one-third. High-dose ibuprofen more than doubled the risk of a major coronary event. Naproxen, by contrast, showed no significant increase in vascular risk at all.
To put the absolute numbers in perspective: for every 1,000 people taking celecoxib or diclofenac daily for a year, about three additional major vascular events occurred compared to placebo, one of them fatal. That sounds small, but it adds up over years of use. If you have existing heart disease or risk factors like high blood pressure, naproxen is generally the safer anti-inflammatory for your cardiovascular system. The trade-off is that naproxen tends to be slightly harder on the stomach than celecoxib.
Cortisone Injections for Flare-Ups
When a single joint is badly inflamed, a cortisone shot can deliver powerful relief within days. These injections work by flooding the joint space with a potent anti-inflammatory, and they’re particularly useful for knees, shoulders, and hips that aren’t responding well enough to oral medications alone.
The limitation is frequency. Repeated cortisone injections can damage cartilage over time, so doctors typically cap how often you receive them in any one joint. There’s no universal number, as the limit depends on the specific joint, the severity of your condition, and how you respond. But the general principle is that cortisone shots are a tool for managing flare-ups, not a long-term maintenance strategy.
Rheumatoid Arthritis: A Different Approach Entirely
Rheumatoid arthritis is an autoimmune disease, meaning your immune system attacks your own joint tissue. Painkillers alone won’t stop the damage. The goal of treatment is to suppress the faulty immune response early, before joints are permanently eroded, using a class of drugs called disease-modifying antirheumatic drugs (DMARDs).
Methotrexate is the established first-line treatment. International guidelines from both the American College of Rheumatology and its European counterpart state that methotrexate should be part of the first treatment strategy for nearly all patients with rheumatoid arthritis. It’s taken once a week (not daily), typically as a pill or self-injection, and it often takes 6 to 12 weeks to reach full effect. Most people tolerate it well, though it requires regular blood tests to monitor liver function and blood cell counts.
If methotrexate alone doesn’t bring the disease under control, the next step is adding a biologic. These are injectable or infused medications that target specific parts of the immune system. The most well-known biologics block a protein called TNF that drives inflammation. Others target different immune pathways. The choice depends on your specific disease pattern and what your body responds to. Several biosimilar versions of major biologics (lower-cost alternatives to brand-name drugs) gained interchangeable status with their reference products in 2024, which is gradually making these treatments more accessible.
JAK Inhibitors: Powerful but With Caveats
A newer class of oral medications called JAK inhibitors offers an alternative to injectable biologics for rheumatoid arthritis. These pills work by blocking enzymes inside immune cells that transmit inflammatory signals. For many patients, the appeal is obvious: a daily pill instead of injections.
However, the FDA now requires boxed warnings on all JAK inhibitors used for arthritis, the most serious safety label a drug can carry. A large clinical trial found that one JAK inhibitor increased the risk of heart attack, stroke, blood clots, cancer (including lymphoma and lung cancer), and death compared to TNF-blocking biologics. Because all drugs in this class work through the same mechanism, the FDA extended these warnings to the entire group.
The practical effect is that JAK inhibitors are now generally reserved for patients who haven’t responded to other treatments. European guidelines specifically flag that people over 65, current or former smokers, and anyone with cardiovascular risk factors or a history of blood clots should be evaluated especially carefully before starting one of these medications. For younger patients without those risk factors who’ve failed other options, JAK inhibitors remain a legitimate choice.
Psoriatic Arthritis: Skin and Joints Together
Psoriatic arthritis sits at the intersection of joint disease and the skin condition psoriasis, and the best medication often depends on which aspect is causing more trouble. Methotrexate is again a common starting point, but biologics that target specific immune molecules called IL-17 and IL-23 have become central to treatment.
IL-17 inhibitors tend to be the stronger option when joint disease is severe. They work well for both peripheral joints (hands, knees, feet) and spinal involvement, making them versatile for people whose disease affects multiple areas. IL-23 inhibitors, on the other hand, have an exceptional safety profile and are well tolerated over long periods. They may be preferred when skin disease is the primary concern or when minimizing side effects is a priority. In practice, many rheumatologists choose between these two classes based on the balance of joint severity, skin involvement, and each patient’s comfort with potential risks.
Matching the Medication to Your Situation
The “best” arthritis medication is ultimately the one that controls your specific disease with the fewest side effects for your particular health profile. A few principles can help you navigate the options:
- Mild osteoarthritis in a single joint: Topical anti-inflammatory gel is a reasonable first step, with oral NSAIDs if that’s not enough.
- Osteoarthritis with heart risk factors: Naproxen carries the lowest cardiovascular risk among common NSAIDs.
- Rheumatoid arthritis, newly diagnosed: Methotrexate is the starting point for nearly everyone, with biologics added if it’s not sufficient.
- Rheumatoid arthritis not responding to biologics: JAK inhibitors are effective but carry significant safety considerations, especially for older adults and smokers.
- Psoriatic arthritis with severe joint involvement: IL-17 inhibitors offer the strongest joint control in this category.
What changes the equation most is time. Osteoarthritis medications manage symptoms but don’t alter the disease course, so the focus stays on pain control and minimizing drug exposure. Rheumatoid and psoriatic arthritis, by contrast, cause progressive joint destruction if undertreated. For these conditions, finding the right medication early and sticking with it can mean the difference between preserved joint function and irreversible damage.